Can Trevi Therapeutics Inc (TRVI) Stock rise from its doldrums?
B. Riley Securities raised the price target for the Trevi Therapeutics Inc (NASDAQ:TRVI) stock to “a Buy”. The rating was released on April 12, 2023, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $14. The stock was initiated by Stifel, who disclosed […]
Getting Ready for the Bounce: Trevi Therapeutics Inc (TRVI) Stock
B. Riley Securities raised the price target for the Trevi Therapeutics Inc (NASDAQ:TRVI) stock to “a Buy”. The rating was released on April 12, 2023, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $14. The stock was initiated by Stifel, who disclosed […]
Trevi Therapeutics Inc (NASDAQ:TRVI) Stock initiated by B. Riley Securities
B. Riley Securities raised the price target for the Trevi Therapeutics Inc (NASDAQ:TRVI) stock to “a Buy”. The rating was released on April 12, 2023, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $14. The stock was initiated by Stifel, who disclosed […]
Trevi Therapeutics Inc (NASDAQ:TRVI) Stock Price Advanced 4.52% to $3.70
B. Riley Securities raised the price target for the Trevi Therapeutics Inc (NASDAQ:TRVI) stock to “a Buy”. The rating was released on April 12, 2023, according to finviz. The research report from SVB Leerink has initiated the stock to Outperform, with a price target set at $14. The stock was initiated by Stifel, who disclosed […]
